Cephea Early Feasibility Study

NARecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

April 28, 2022

Primary Completion Date

March 1, 2026

Study Completion Date

March 1, 2031

Conditions
Mitral Regurgitation
Interventions
DEVICE

Cephea Mitral Valve System

Transcatheter mitral valve replacement

Trial Locations (21)

10032

NOT_YET_RECRUITING

New York-Presbyterian/Columbia University Medical Center, New York

10467

RECRUITING

Montefiore Medical Center - Moses Division, The Bronx

15212

ACTIVE_NOT_RECRUITING

Allegheny General Hospital - ASRI, Pittsburgh

23507

NOT_YET_RECRUITING

Sentara Norfolk General Hospital, Norfolk

28203

RECRUITING

Atrium Health - Carolinas Medical Center, Charlotte

30308

ACTIVE_NOT_RECRUITING

Emory University Hospital, Atlanta

30309

RECRUITING

Piedmont Heart Institute, Atlanta

37205

RECRUITING

Ascension Saint Thomas, Nashville

37208

NOT_YET_RECRUITING

Vanderbilt Heart & Vascular Institute, Nashville

44195

RECRUITING

The Cleveland Clinic Foundation, Cleveland

48109

RECRUITING

University of Michigan, Ann Arbor

55407

RECRUITING

Minneapolis Heart Institute, Minneapolis

60611

ACTIVE_NOT_RECRUITING

Northwestern Memorial Hospital, Chicago

67214

RECRUITING

Via Christi Regional Medical Center - St. Francis Campus, Wichita

77030

RECRUITING

Houston Methodist, Houston

90048

RECRUITING

Cedars-Sinai Medical Center, Los Angeles

91360

ACTIVE_NOT_RECRUITING

Los Robles Regional Medical Center, Thousand Oaks

95817

RECRUITING

University of California - Davis Medical Center, Sacramento

98122

NOT_YET_RECRUITING

Swedish Medical Center, Seattle

Unknown

COMPLETED

Institut de Cardiologie de Montreal, Montreal

G1V 4G5

ACTIVE_NOT_RECRUITING

Institut de Cardiologie de Quebec, Québec

Sponsors
All Listed Sponsors
lead

Abbott Medical Devices

INDUSTRY